{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:07:00Z","timestamp":1762866420765},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.lfs.2014.06.003","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T22:32:05Z","timestamp":1402612325000},"page":"20-29","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131"],"prefix":"10.1016","volume":"109","author":[{"given":"Lex","family":"Van der Ploeg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley","family":"Laken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Halem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Touvay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Teillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lou","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz","family":"Stoner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Gottesdiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Culler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2014.06.003_bb0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.archger.2010.10.004","article-title":"MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study","volume":"53","author":"Adunsky","year":"2011","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"10.1016\/j.lfs.2014.06.003_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s13300-010-0010-8","article-title":"Diabetic gastroparesis: therapeutic options","volume":"1","author":"Alam","year":"2010","journal-title":"Diabetes Ther"},{"issue":"2","key":"10.1016\/j.lfs.2014.06.003_bb0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2012.10.018","article-title":"Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology","volume":"162","author":"Anker","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.lfs.2014.06.003_bb0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrgastro.2009.72","article-title":"Actions and therapeutic pathways of ghrelin for gastrointestinal disorders","volume":"6","author":"Camilleri","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.lfs.2014.06.003_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/mcp.2001.116514","article-title":"Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin like growth factor I axis in growth hormone-deficient children","volume":"70","author":"Codner","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lfs.2014.06.003_bb0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4522(03)00327-0","article-title":"Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin","volume":"120","author":"Dass","year":"2003","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.lfs.2014.06.003_bb0035","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1210\/endo.141.11.7757","article-title":"Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans","volume":"141","author":"Date","year":"2000","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.lfs.2014.06.003_bb0325","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2002.01195.x","article-title":"The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers","volume":"16","author":"De Schryver","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lfs.2014.06.003_bb0255","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/189242","article-title":"Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations","volume":"2011","author":"DeBoer","year":"2011","journal-title":"Int J Pept"},{"issue":"6","key":"10.1016\/j.lfs.2014.06.003_bb0100","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","article-title":"Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia","volume":"148","author":"DeBoer","year":"2007","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.lfs.2014.06.003_bb0265","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/en.2007-1046","article-title":"Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile","volume":"149","author":"DeBoer","year":"2008","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.lfs.2014.06.003_bb0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrgastro.2012.57","article-title":"The migrating motor complex: control mechanisms and its role in health and disease","volume":"9","author":"Deloose","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.lfs.2014.06.003_bb0270","doi-asserted-by":"crossref","unstructured":"Dong ZX, US Patent 7,456,253; dated Nov 25, 2008.","DOI":"10.1080\/01490450802426884"},{"key":"10.1016\/j.lfs.2014.06.003_bb0220","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1365-2036.2009.03986.x","article-title":"Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis","volume":"29","author":"Ejskjaer","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.lfs.2014.06.003_bb0180","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1111\/nmo.12064","article-title":"A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis. Neurogastroneterol Motil, 2013; 25(2): 140","volume":"25","author":"Ejskjaer","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.lfs.2014.06.003_bb0090","article-title":"Update on ghrelin. Ghrelin, des-acyl ghrelin, and obestatin: regulatory roles on the gastrointestinal motility","volume":"2010","author":"Fetissov","year":"2010","journal-title":"Int J Pept"},{"issue":"12","key":"10.1016\/j.lfs.2014.06.003_bb0120","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1210\/en.2008-0804","article-title":"Pharmacological demarcation of the growth hormone, gut motility and feeding effects of ghrelin using a novel ghrelin receptor agonist","volume":"149","author":"Fraser","year":"2008","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.lfs.2014.06.003_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF03344083","article-title":"Ghrelin tissue distribution: comparison between gene and protein expression","volume":"29","author":"Ghelardoni","year":"2006","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"10.1016\/j.lfs.2014.06.003_bb0215","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1023\/A:1018955126402","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers","volume":"16","author":"Gobburu","year":"1999","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.lfs.2014.06.003_bb0305","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/16.1.24","article-title":"Quantification of protein solutions with Trinitrobenzenesulfonic acid","volume":"16","author":"Goodwin","year":"1970","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.lfs.2014.06.003_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-328X(97)00071-5","article-title":"Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues","volume":"48","author":"Guan","year":"1997","journal-title":"Mol Brain Res"},{"issue":"2","key":"10.1016\/j.lfs.2014.06.003_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MCC.0b013e3283514b01","article-title":"Ghrelin, appetite and critical illness","volume":"18","author":"Hill","year":"2012","journal-title":"Curr Opin Crit Care"},{"issue":"24","key":"10.1016\/j.lfs.2014.06.003_bb0195","doi-asserted-by":"crossref","first-page":"8305","DOI":"10.1021\/jm2007062","article-title":"Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (part 1): development of ulimorelin (TZP-101) from hit to clinic","volume":"54","author":"Hoveyda","year":"2011","journal-title":"J Med Chem"},{"issue":"5277","key":"10.1016\/j.lfs.2014.06.003_bb0015","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.273.5277.974","article-title":"A new G-protein coupled receptor of the pituitary and hypothalamus involved in pulsatile GH release","volume":"273","author":"Howard","year":"1996","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.lfs.2014.06.003_bb0065","article-title":"Ghrelin receptor expression and activities in the mouse gastrointestinal tract","volume":"8","author":"Jolly","year":"2010","journal-title":"Proc Br Pharmacol Soc"},{"key":"10.1016\/j.lfs.2014.06.003_bb0260","series-title":"ACG 2012 Annual Scientific Meeting Abstracts","article-title":"RM-131, A novel ghrelin analog, demonstrates potent prokinetic activity in Phase I single- and multiple-dose studies in healthy volunteers. Program No. P1011","author":"Kaplan","year":"2012"},{"issue":"2","key":"10.1016\/j.lfs.2014.06.003_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.00012.2004","article-title":"Ghrelin: structure and function","volume":"85","author":"Kojima","year":"2005","journal-title":"Physiol Rev"},{"issue":"6762","key":"10.1016\/j.lfs.2014.06.003_bb0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from the stomach","volume":"204","author":"Kojima","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2014.06.003_bb0245","first-page":"285","article-title":"Opiates and the gastrointestinal tract","volume":"74","author":"Konturek","year":"1980","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.lfs.2014.06.003_bb0135","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1210\/jc.2004-2537","article-title":"Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy","volume":"90","author":"Le Roux","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lfs.2014.06.003_bb0230","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12184","article-title":"Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghelin receptor agonist for diabetic gastroparesis","author":"McCallum","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.lfs.2014.06.003_bb0250","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0016-5085(89)80079-4","article-title":"Hapten-induced model of chronic inflammation and ulceration in the rat colon","volume":"96","author":"Morris","year":"1989","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.lfs.2014.06.003_bb0210","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-149-9-200811040-00003","article-title":"Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial","volume":"149","author":"Nass","year":"2008","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.lfs.2014.06.003_bb0105","doi-asserted-by":"crossref","first-page":"e26865","DOI":"10.1371\/journal.pone.0026865","article-title":"Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model","volume":"6","author":"Palus","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.lfs.2014.06.003_bb0040","first-page":"3803","article-title":"Growth hormone secretagogue binding sites in peripheral human tissues","volume":"85","author":"Papotti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"46","key":"10.1016\/j.lfs.2014.06.003_bb0110","doi-asserted-by":"crossref","first-page":"19003","DOI":"10.1073\/pnas.1209590109","article-title":"Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release","volume":"109","author":"Park","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.lfs.2014.06.003_bb0150","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/jc.2006-2160","article-title":"Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects","volume":"92","author":"Piccoli","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.lfs.2014.06.003_bb0145","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.peptides.2005.02.010","article-title":"Gastrokinetic effect of ghrelin analog RC-1139 in the rat, effect on post-operative and on morphine induced ileus","volume":"26","author":"Poitras","year":"2005","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.lfs.2014.06.003_bb0315","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/sj.bjp.0702665","article-title":"Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle","volume":"127","author":"Prins","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.lfs.2014.06.003_bb0320","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.bjp.0703615","article-title":"5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle","volume":"131","author":"Prins","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.003_bb0280","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/nmo.12259","article-title":"The mechanism of enhanced defecation caused by the ghrelin agonist, ulimorelin","volume":"26","author":"Pustovit","year":"2014","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"10.1016\/j.lfs.2014.06.003_bb0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000334903","article-title":"MC4 dimerization in the paraventricular nucleus and GHSR\/MC3R heterodimerization in the arcuate nucleus: is there relevance for body weight regulation?","volume":"95","author":"Rediger","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.lfs.2014.06.003_bb0300","doi-asserted-by":"crossref","first-page":"e3098","DOI":"10.1371\/journal.pone.0030985","article-title":"The JNK inhibitor XG-102 Protects against TNBS-induced Colitis","volume":"7","author":"Reinecke","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.lfs.2014.06.003_bb0275","first-page":"649","article-title":"Pharmacological effect on gastric emptying following laparotomy in the rat","volume":"141","author":"Rentzhog","year":"1975","journal-title":"Acta Chir Scand"},{"key":"10.1016\/j.lfs.2014.06.003_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1519s49","article-title":"Induction of TNBS colitis in mice","author":"Scheiffele","year":"2002","journal-title":"Curr Protoc Immunol"},{"issue":"5","key":"10.1016\/j.lfs.2014.06.003_bb0285","doi-asserted-by":"crossref","first-page":"S-363","DOI":"10.1016\/S0016-5085(14)61313-5","article-title":"Effects of RM-131 on circular smooth muscle in human and mouse colon and colonic intraluminal pressure in conscious mice","volume":"146","author":"Sha","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lfs.2014.06.003_bb0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2982.2008.01176.x","article-title":"Oral Administration of a centrally acting ghrelin receptor agonist to conscious rats triggers defecation","volume":"21","author":"Shafton","year":"2009","journal-title":"Neurogastroenterol Motil"},{"issue":"7","key":"10.1016\/j.lfs.2014.06.003_bb0200","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/DCR.0b013e31829196d0","article-title":"Safety and efficacy of ulimorelin administered postoperatively to accelerate recovery of gastrointestinal motility following partial bowel resection: results of two randomized, placebo-controlled phase 3 trials","volume":"56","author":"Shaw","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.lfs.2014.06.003_bb0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1113\/jphysiol.2006.116160","article-title":"Evidence that stimulation of ghrelin receptors in the spinal cord intiates propulsive activity in the colon of the rat","volume":"576","author":"Shimizu","year":"2006","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.lfs.2014.06.003_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/dc12-1128","article-title":"Randomized controlled phase Ib study of ghrelin agonist, RM-131, in Type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics","volume":"36","author":"Shin","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2014.06.003_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.04.019","article-title":"The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with Type 1 diabetes mellitus","author":"Shin","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.lfs.2014.06.003_bb0140","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/er.2004-0019","article-title":"Development of growth hormone secretagogues","volume":"26","author":"Smith","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.lfs.2014.06.003_bb0005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/edrv.18.5.0316","article-title":"Peptidomimetic regulation of growth hormone secretion","volume":"18","author":"Smith","year":"1998","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.lfs.2014.06.003_bb0290","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1471-4159.1986.tb00742.x","article-title":"Neurotensin stimulates inositol phospholipid metabolism and calcium mobilization in murine neuroblastoma clone N1E-115","volume":"47","author":"Snider","year":"1986","journal-title":"J Neurochem"},{"issue":"8","key":"10.1016\/j.lfs.2014.06.003_bb0235","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/j.1460-9568.2007.05856.x","article-title":"Role of the corticotropin releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis","volume":"26","author":"Tabarin","year":"2007","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.lfs.2014.06.003_bb0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/14728214.2011.558502","article-title":"Emerging drugs for functional dyspepsia","volume":"16","author":"Tack","year":"2011","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.lfs.2014.06.003_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-230X-5-5","article-title":"Central Neuropeptide Y receptors are involved in 3rd ventricular ghrelin induced alteration of colonic transit time in conscious fed rats","volume":"5","author":"Tebbe","year":"2005","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.lfs.2014.06.003_bb0185","series-title":"Discovery Chemistry. Constrained Peptides and Macrocyclics Drug Discovery Novel Peptide Therapeutics Symposium. San Diego, CA April 16-17, 2013","article-title":"Discovery of TZP-102. A macrocycle based oral ghrelin receptor agonist and GI prokinetic agent for the treatment of diabetic gastroparesis","author":"Thomas","year":"2013"},{"issue":"16","key":"10.1016\/j.lfs.2014.06.003_bb0030","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1073\/pnas.1002271107","article-title":"Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice","volume":"107","author":"Tong-Jin","year":"2010","journal-title":"Proc Natl Acad Sci"},{"issue":"6806","key":"10.1016\/j.lfs.2014.06.003_bb0080","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/35038090","article-title":"Ghrelin induces adiposity in rodents","volume":"407","author":"Tsch\u00f6p","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.lfs.2014.06.003_bb0085","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tsch\u00f6p","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2014.06.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/879503","article-title":"Integrating GHS into the ghrelin system","volume":"2010","author":"Veldhuis","year":"2010","journal-title":"Int J Pept"},{"issue":"4","key":"10.1016\/j.lfs.2014.06.003_bb0155","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1210\/jc.2008-0632","article-title":"Effects of an oral growth hormone secretagogue in older adults","volume":"94","author":"White","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.lfs.2014.06.003_bb0170","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2036.2010.04567.x","article-title":"Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting\u2014randomised clinical study subset data","volume":"33","author":"Wo","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lfs.2014.06.003_bb0310","first-page":"49","article-title":"Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation","volume":"3","author":"Wong","year":"2010","journal-title":"Clin Exp Gastroenterol"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514005347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514005347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:17:53Z","timestamp":1597965473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320514005347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0024320514005347"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2014.06.003","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2014.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}